ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: While the CML and CML-derived iPSCs both expressed BCR-ABL, the CML-iPSCs were resistant to imatinib in contrast to their imatinib-sensitive CML parental line [60].